The report analyzes and
presents an overview of "
Travelers Diarrhea - Pipeline Review, H1 2016 "
worldwide.
Global
Markets Directs, Traveler's
Diarrhea - Pipeline Review, H1 2016,
provides an overview of the Traveler's Diarrhea pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Traveler's Diarrhea, complete with analysis by stage
of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Traveler's Diarrhea and features
dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report at
Scope
- The report provides a
snapshot of the global therapeutic landscape of Traveler's Diarrhea
- The report reviews pipeline
therapeutics for Traveler's Diarrhea by companies and
universities/research institutes based on information derived from
company and industry-specific sources
- The report covers pipeline
products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- The report features
descriptive drug profiles for the pipeline products which includes,
product description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key
players involved Traveler's Diarrhea therapeutics and enlists all
their major and minor projects
- The report assesses
Traveler's Diarrhea therapeutics based on drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the
dormant and discontinued pipeline projects
- The report reviews latest
news related to pipeline therapeutics for Traveler's Diarrhea
Reasons to buy
- Gain strategically
significant competitor information, analysis, and insights to
formulate effective R&D strategies
- Identify emerging players
with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Identify and understand
important and diverse types of therapeutics under development for
Traveler's Diarrhea
- Identify potential new
clients or partners in the target demographic
- Develop strategic initiatives
by understanding the focus areas of leading companies
- Plan mergers and acquisitions
effectively by identifying key players and its most promising
pipeline therapeutics
- Devise corrective measures
for pipeline projects by understanding Traveler's Diarrhea pipeline
depth and focus of Indication therapeutics
- Develop and design
in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand
business potential and scope
- Modify the therapeutic
portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline
Table
of Contents
Table
of Contents 2
List
of Tables 5
List
of Figures 5
Introduction
6
Global
Markets Direct Report Coverage 6
Traveler's
Diarrhea Overview 7
Therapeutics
Development 8
Pipeline
Products for Traveler's Diarrhea - Overview 8
Pipeline
Products for Traveler's Diarrhea - Comparative Analysis 9
Traveler's
Diarrhea - Therapeutics under Development by Companies 10
Traveler's
Diarrhea - Therapeutics under Investigation by
Universities/Institutes 11
Traveler's
Diarrhea - Pipeline Products Glance 12
Late
Stage Products 12
Clinical
Stage Products 13
Early
Stage Products 14
Traveler's
Diarrhea - Products under Development by Companies 15
Traveler's
Diarrhea - Products under Investigation by Universities/Institutes 16
Traveler's
Diarrhea - Companies Involved in Therapeutics Development 17
Chiesi
Farmaceutici SpA 17
Cosmo
Pharmaceuticals S.p.A 18
GlaxoSmithKline
Plc 19
Nippon
Shinyaku Co., Ltd. 20
Prokarium
Limited 21
Scandinavian
Biopharma Holding AB 22
Sigmoid
Pharma Limited 23
Traveler's
Diarrhea - Therapeutics Assessment 24
Assessment
by Monotherapy Products 24
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment